The role of high-deductible health plans on the use of lenalidomide
Publication
, Conference
Jazowski, SA; Wilson, L; Dusetzina, SB; Zafar, Y; Zullig, LL
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
2020
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2020
Volume
29
Start / End Page
267 / 267
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jazowski, S. A., Wilson, L., Dusetzina, S. B., Zafar, Y., & Zullig, L. L. (2020). The role of high-deductible health plans on the use of lenalidomide. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 29, pp. 267–267).
Jazowski, Shelley A., Lauren Wilson, Stacie B. Dusetzina, Yousuf Zafar, and Leah L. Zullig. “The role of high-deductible health plans on the use of lenalidomide.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 29:267–267, 2020.
Jazowski SA, Wilson L, Dusetzina SB, Zafar Y, Zullig LL. The role of high-deductible health plans on the use of lenalidomide. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020. p. 267–267.
Jazowski, Shelley A., et al. “The role of high-deductible health plans on the use of lenalidomide.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 29, 2020, pp. 267–267.
Jazowski SA, Wilson L, Dusetzina SB, Zafar Y, Zullig LL. The role of high-deductible health plans on the use of lenalidomide. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020. p. 267–267.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2020
Volume
29
Start / End Page
267 / 267
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences